COVID Vaccine Trial Administers 1st Dose To Participant
CORONAVIRUS VACCINE TRIAL ADMINISTERS FIRST DOSE TO PARTICIPANT
(CNN) – It’s an important first step in finding a safe and effective vaccine for COVID-19.
A participant in a coronavirus vaccine trial in the U.S. has been administered their first dose.
The National Institute of Allergy and Infectious Diseases is funding the trial and made the announcement on Monday.
The study aims to enroll a total of 45 healthy adults over a six-week time frame.
Each participant will receive two injections about a month apart in varying doses.
The study is meant to prove that the vaccine is safe and induces a desired response from participants’ immune systems.
However, experts say proving the vaccine is effective in preventing COVID-19 infection, will require follow-up studies involving many more participants.
And that would take many more months.
The trial is run out of the Kaiser Permanente Washington Health Research Institute in Seattle.